Frederick Health's Groundbreaking Collaboration with MEDITECH and GenomOncology in Precision Medicine

Wednesday, February 28, 2024

Frederick Health, a prominent healthcare system based in Frederick County, Maryland, has embraced GenomOncology's Precision Oncology Platform, which integrates smoothly with the renowned MEDITECH Expanse Genomics solution, to enhance its precision medicine initiatives. Operating across 25 locations and boasting a workforce of over 4,000 professionals, Frederick Health is deeply committed to delivering a wide array of healthcare and wellness services. As part of its ongoing efforts to expand its program offerings and better serve the needs of its community, Frederick Health has successfully integrated Expanse Genomics into its MEDITECH Expanse Electronic Health Record (EHR) system.

This strategic integration enables Frederick Health's healthcare practitioners to request genetic tests, analyze results, and devise treatment plans tailored to individual genetic profiles directly within their Expanse EHR workflow. In addition to implementing Expanse Genomics, Frederick Health has leveraged GenomOncology's Precision Oncology Platform within Expanse Genomics to further enhance its precision medicine capabilities. Facilitated by the GenomOncology Precision Oncology API Suite and a seamless integration developed jointly by MEDITECH and GenomOncology, this integration expands access to comprehensive precision medicine information within the EHR, thereby strengthening decision support capabilities.

The GenomOncology Precision Oncology Platform aggregates the latest precision oncology insights, including a wealth of annotations, ontologies, and curated content from various sources, both public and proprietary. With this platform in place, Frederick Health gains access to meticulously curated precision oncology data, including information on clinical trials and approved therapies, which enables their team to make well-informed recommendations for patients more efficiently.

This innovative solution represents a groundbreaking approach, integrating vast amounts of EHR data to enable organizations like Frederick Health to access matched therapies and clinical trials seamlessly within their everyday EHR workflows. By combining the capabilities of the GenomOncology Precision Oncology Platform with the expertise provided by the MEDITECH Expanse Genomics solution, Frederick Health's clinicians and researchers are empowered with the knowledge necessary to optimize their patients' treatment opportunities.




Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress